Treatment options for PNET liver metastases: a systematic review

Abstract Background Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40–80% of patients with PNET are metastatic at presentation, usually involving the liver (40–93%). Liver metastasis represents the most significant prognostic factor. The aim of this study is to present...

Full description

Bibliographic Details
Main Authors: Giuseppe Nigri, Niccolò Petrucciani, Tarek Debs, Livia Maria Mangogna, Anna Crovetto, Giovanni Moschetta, Raffaello Persechino, Paolo Aurello, Giovanni Ramacciato
Format: Article
Language:English
Published: BMC 2018-07-01
Series:World Journal of Surgical Oncology
Online Access:http://link.springer.com/article/10.1186/s12957-018-1446-y